FDA 483 OBSERVATION · #289 OF 1,945 MOST-CITED
Required records
FDA cited this observation 103 times across 83 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0× the rate of the average FDA-cited firm (0.0% vs 7.8%), across 83 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Failure to maintain processing, storage and distribution, quality control and general records.
Failure to maintain storage and distribution records.
Failure to maintain storage and distribution and quality control records.
Failure to maintain donor records.
Failure to maintain donor, processing, quality control and general records.
Failure to maintain processing, quality control and general records.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →